Schedule 13G ownership disclosure

Onconova Therapeutics, Inc.

Security class unavailable · CUSIP: 68232V108

Event date: 2017-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
702,896
Percent of class
7.6100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-17-000081
Form type
SC 13G
Filer
Traws Pharma, Inc.
CIK
CIK 1130598
Filed
May 01, 2017
Reporting period
Apr 21, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub